Several clinical trials of inhaled RNA therapy have been initiated including delivery of siRNAs for asthma (Excellair) and RSV infection (ALN-RSV01), full CFTR mRNA delivery for CF (MRT5005) and an antisense oligo also for CF (Eluforsen). Here, CFTR is linked to asthma.